ulcerrative colitis
Download
Skip this Video
Download Presentation
ULCERRATIVE COLITIS

Loading in 2 Seconds...

play fullscreen
1 / 56

ULCERRATIVE COLITIS - PowerPoint PPT Presentation


  • 190 Views
  • Uploaded on

ULCERRATIVE COLITIS. PROF. WU SHUMING. Ulcerative Colitis.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' ULCERRATIVE COLITIS' - dandre


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
ulcerrative colitis

ULCERRATIVE COLITIS

PROF. WU SHUMING

ulcerative colitis
Ulcerative Colitis
  • Ulcerative colitis is a chronic disorder of still unknown aetiology, characterized by inflammation limited to the colonic mucosa, and by an intermittent, relapsing clinical course. It has a prevalence of almost 100 in 10,0000 in the West.
epidemiology of inflammatory bowel disease
Epidemiology of Inflammatory Bowel Disease

FACTOR ULCERATIVE COLITIS

Incidence 2 - 10

Prevalence 35 - 100

Racial incidence High in caucasian

Ethnic indicence High in Jews

Gender Slight female

preponderance

Age at onset 15 - 25

? 55 - 65

Fewer smokers than

expected

pathophysiology
pathophysiology
  • An immunologic mechanism in the pathogenesis is assumed, but the inciting causes are not known.
  • Hereditary factors: patients with ulcerative colitis have a 10-15% chance of having a first- or second-degree relative who also has one or the other type of inflammatory bowel disease.
  • intestinal inflammations : present with signs and symptoms similar to those of ulcerative colitis
pathology
Pathology

It affects the rectum, and extends in continuity to involve a variable extent of the proximal colon, so that the patient may have proctitis alone, proctosigmoiditis, left-sided disease ( from the splenic flexure), or subtotal or total colitis. radiological grounds,

slide10

Total colitis may be associated with inflammation of the terminal ileum - known as backwash ileitis - if the ileocaecal valve is incompetent

backwash ileitis

pathology1
Pathology
  • In ulcerative colitis, the mucosal surface becomes irregular and granular. The mucosa is friable, meaning that it bleeds easily when touched. With more severe inflammation, bleeding may be spontaneous. In some patients with chronic ulcerative colitis, pseudopolyps develop.
clinical presentation
clinical presentation

The clinical presentation of ulcerative colitis depends on the length of colon involved and the severity of the episode. It is semiquantitatively classified by the presence or absence of systemic features such as pyrexia, tachycardia, anaemia; by the frequency of defaecation; and by the quantity of rectal blood loss. Bloody diarrhoea, often with tenesmus, is usual at presentation.

signs and symptoms
Signs and symptoms.
  • Patients with ulcerative colitis typically complain of bloody stool. If the inflammation is confined to the rectum, stools may be pure blood.
signs and symptoms1
Signs and symptoms.
  • Pallor due to anemia of blood loss or chronic disease may be evident.
  • Tachycardia may result from dehydration and diminished blood volume
  • Low-grade fever may be present.
  • Mild-to-moderate abdominal tenderness is characteristic of ulcerative colitis.
  • The rectal examination in patients with ulcerative colitis reveals bloody stool or frank blood,
signs and symptoms2
Signs and symptoms.
  • Growth retardation and failure to develop sexual maturity

In fact, these complications may be the primary reason for the patient\'s consulting a physician. Growth failure is rarely caused by endocrine abnormalities but rather is a consequence of reduced caloric and nutritional intake or utilization. Treatment of the ulcerative colitis with attention to good nutrition, usually results in reestablishment of normal growth and development.

signs and symptoms3
Signs and symptoms.
  • Abdominal distention, rebound tenderness, absence of bowel sounds, and high fever suggest toxic megacolon
clinical course of uc
Clinical Course of UC

NUMBER OF PATIENTS PERCENTAGE

Acute fulminating 20 8.0

Chronic intermittent 161 64.4

Chronic continuous 18 7.2

One attack only 45 18.0

Total colectomy in first attack 2 0.8

Died in first attack of other causes 1 0.4

Unknown 2 0.8

Total 249 100.0

onset and course of symptoms
Onset and course of symptoms.
  • Ulcerative colitis typically begin in childhood or early adulthood, although ulcerative colitis may develop in patients of any age.
  • Most patients with ulcerative colitis experience intermittent exacerbations with nearly complete remissions between attacks.
  • In ulcerative colitis, about 5-10% of patients have one attack without subsequent symptoms for decades.
  • A similar number have continuous symptoms, and some have a fulminating course requiring total proctocolectomy.
complications of uc
Complications of UC
  • Chronic ulcerative colitis predisposes to adenocarcinomaof the colon
  • toxic megacolon
conditions that predispose to colon cancer
Conditions that predispose to colon cancer

Advancing age

Family history of colorectal cancer or polyps

High-fat, low-fiber diet

Bowel disorders

Inflammatory bowel disease (ulcerative colitis, Crohn\'s

disease)

Adenomatous polyps

Some polyposis syndromes

Family cancer syndrome

Genital tract cancer in women

toxic megacolon
Toxic Megacolon

In severe colitis of any cause, the transverse colon may become dilated . When this finding is accompanied by fever, elevated white cell count, and abdominal tenderness, toxic megacolon is likely

criteria for severe colitis
Criteria for Severe Colitis

1.Diarrhea: 6 stools/per day or more with macroscopic blood

2.Fever: Mean evening temp.>37.5C or a temp. of >37.8C on at least 2 days out of 4.

3.Erythrocyte sedimentation rate elevation >30

4.Anemia: Hemoglobin level <115 g / liter

5.Tachycardia: Mean pulse rate > 90 /min

Truelove-Lancet 1974;1:1067

colonoscopic mucosal features and their diagnostic specificity in ibd
Colonoscopic Mucosal Features and Their Diagnostic Specificity in IBD

LESION UC CD

Inflammation

Distribution

Colon

Contiguous +++ +

Symmetric +++ +

Rectum +++ +

Friability +++ +

Topography

Granularity +++ +

Cobblestoned + +++

colonoscopic mucosal features and their diagnostic specificity inibd
Colonoscopic Mucosal Features and Their Diagnostic Specificity inIBD

LESION UC CD

Ulceration

Location

Overt colitis +++ +

Ileum 0 ++++

Discrete lesion + +++

Features

Size >1 cm + +++

Deep + ++

Linear + +++

Aphthoid 0 ++++

Bridging + ++

ulcerative colitis versus crohn s disease
Ulcerative colitis versus Crohn\'s disease

Ulcerative colitis Crohn\'s disease

Pain crampy, lower abdominal, Pain constant, often in relieved by bowel movement right lower quadrant,

not relieved by bowel movement Bloody stool Stool usually not grossly bloody

No abdominal mass Abdominal mass, often in

right lower quadrant

Affects only colon May affect small and

large bowel, occasionally

esophagus and stomach

Mucosal disease (granulomas Transmural disease

are not a feature) (granulomas found in a

minority of patients)

Continuous from rectum May be discontinuous

(skip areas)

differential diagnosis of ibd
Bacterial colitis

Campylobacter

Shigella

Salmonella

Escherichia coli (invasive)

Clostridium difficile--associated colitis

Parasitic colitis

Amebiasis

Schistosomiasis

Ischemic colitis

Radiation colitis

Behcet\'s colitis

Sexually transmitted colitis

Gonococcus

Chlamydia

Herpes

Trauma

Crohn\'s disease look-alikes

Lymphoma

Yersinia

Tuberculosis

* IBD = inflammatory bowel disease

Differential diagnosis of IBD
laboratory test
a The CBC may document anemia and leukocytosis,

b. Stool studies. Stool samples should be examined for ova and parasites, cultured, and tested for C. difficile toxin.

c. Abdominal plain x-ray films.

d. Sigmoidoscopy. flexible instrument, The severity of the mucosal injury can be assessed, and other conditions in the differential diagnosis, such as Crohn\'s disease, ischemic colitis, and pseudomembranous colitis, may be implicated.

e. Colonoscopy and barium enema are contraindicated in severe colitis or toxic megacolon.

Laboratory Test
extraintestinal manifestations of ibd
Extraintestinal manifestations of IBD*

Common to both ulcerative colitis and Crohn\'s disease

___________________________________

Area Condition Conditions related to Crohn\'s

Joints Peripheral arthritis Gallstones

Sacroiliitis Renal oxylate stones

Ankylosing spondylitis Vitamin B[12] deficiency

Obstructive hydronephrosis Skin Erythema nodosum

Pyoderma gangrenosum

Eyes Conjunctivitis

Iritis ,Episcleritis

Liver Fatty infiltration

Chronic active hepatitis

Pericholangitis

Sclerosing cholangitis

Bile duct carcinoma

Kidneys Pyelonephritis

Renal stones

General Amyloidosis* IBD = inflammatory bowel disease

sulfasalazine sasp
Sulfasalazine (SASP)
  • SASP: Two moieties of 5-aminosalicylic acid(5-ASA) and sulfapyridine(SP)
  • 20~30% is absorbed in SASP in upper GI, excreted from bile and urine
  • Intestinal bacteria break-down the other SASP into SP and 5-ASA
  • Absorbed lipophilic SP: side-effect
  • Poorly lipophilic remains in the colon
adverse effects of sulfasazine
Dose related

nausea

vomiting

anorexia

folate mal-ab.

Headache

alopecia

Not dose related

skin rash

hemolytic anemia

agrannulocytosis

fibrosing alveolitis

hepatitis

male infertility

colitis

Adverse Effects of Sulfasazine
new salicylate drugs
MESALAZINE

PREPARATIONS

Enteric-coated Ctrl.-Released

Asacol Pentasa

Claversal

Salofalk

Rowasa

Prodrug

Osalazine

Balsalazide

Mesalazine

NEW SALICYLATE DRUGS
mechanisms of steroid action ibd
Mechanisms of Steroid Action-IBD
  • Stabilizes lysosomal membranes
  • Reduces capillary permeability
  • Function as inhibitors of chemotaxis and phagocytosis
  • Impairs cell-mediated immunity in experimental models
administration and dosage
Administration and Dosage
  • Oral

Dosage

Tapering

  • Intravenous

Bolus or continuous infusion

  • Topical

Position, Dosage, Duration

slide54

Ileorectal anastomosis

Brooke ileostomy

ad